TC Biopharm (Holdings)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of TC Biopharm (Holdings) generated cash of -$10,544,870, which is more than the previous year. Cash used in financing activities reached the amount of $8,520,376 last year. Net change in cash is therefore -$2,345,451.
Cash Flow
| 2019 | -6.72M | -2.19M | 3.27M |
|---|---|---|---|
| 2020 | -3.43M | -204.99K | 3.43M |
| 2021 | -5.58M | -143.22K | 6.52M |
| 2022 | -15.29M | -310.19K | 18.65M |
| 2023 | -10.54M | -208.78K | 8.52M |
TCBPW Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 4.80M | 1.56M | 748.01K | 956.49K | 0 |
Operating activities | |||||
Net income | -5.90M | -1.31M | -14.98M | -6.62M | -6.06M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 633.00K | 959.04K | 1.02M | 1.07M | 904.46K |
Stock-based compensation expense | 444.45K | 1.12M | 0 | 804.71K | 835.79K |
| Deferred income tax benefit | 444.45K | 1.12M | 0 | 804.71K | 835.79K |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 676.40K | -37.50K | -591.61K | 1.72M | 258.04K |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -10.54M | -15.29M | -5.58M | -3.43M | -6.72M |
Investing activities | |||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -110.35K | -240.71K | -143.22K | -204.99K | -2.02M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -208.78K | -310.19K | -143.22K | -204.99K | -2.19M |
Financing activities | |||||
Common Stock Issued | 4.18M | 3.36M | 285.10K | 3.89M | 3.13M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -2.61M | -122.46K | -415.27K | 135.53K |
Cash used in financing activities | 8.52M | 18.65M | 6.52M | 3.43M | 3.27M |
Net Change In Cash | -2.34M | 3.24M | 818.67K | -208.48K | 956.49K |
Cash at end of period | 2.46M | 4.80M | 1.56M | 748.01K | 956.49K |
| Data source | Data source | Data source |